| scholarly article | Q13442814 |
| P50 | author | Gordon B. Mills | Q28086262 |
| Hyun Goo Woo | Q55459000 | ||
| Jae-Ho Cheong | Q63644867 | ||
| Levi A Garraway | Q89916155 | ||
| Bryan T. Hennessy | Q117214243 | ||
| P2093 | author name string | Yiling Lu | |
| Eun Sung Park | |||
| Ju-Seog Lee | |||
| Sang-Bae Kim | |||
| John N Weinstein | |||
| Michael A Davies | |||
| Wenbin Liu | |||
| Wanleng Deng | |||
| Mark Carey | |||
| Zhenlin Ju | |||
| Roshan Agarwal | |||
| Rosalia Rabinovsky | |||
| P2860 | cites work | An integrative genomic and proteomic approach to chemosensitivity prediction | Q23909225 |
| Systematic variation in gene expression patterns in human cancer cell lines | Q28145747 | ||
| The NCI60 human tumour cell line anticancer drug screen | Q29614975 | ||
| A gene expression database for the molecular pharmacology of cancer | Q29619242 | ||
| A strategy for predicting the chemosensitivity of human cancers and its application to drug discovery | Q30443764 | ||
| Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays | Q30449558 | ||
| Establishing connections between microarray expression data and chemotherapeutic cancer pharmacology | Q30756529 | ||
| Integrating data on DNA copy number with gene expression levels and drug sensitivities in the NCI-60 cell line panel | Q31038779 | ||
| Synthetic lethal screen identification of chemosensitizer loci in cancer cells | Q33281866 | ||
| Gene expression patterns within cell lines are predictive of chemosensitivity | Q33318982 | ||
| DNA fingerprinting of the NCI-60 cell line panel | Q33608214 | ||
| Chemosensitivity prediction by transcriptional profiling | Q33943845 | ||
| Asparagine synthetase is a predictive biomarker of L-asparaginase activity in ovarian cancer cell lines. | Q34011217 | ||
| AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer | Q34990362 | ||
| Dickkopf-1 activates cell death in MDA-MB435 melanoma cells | Q35664806 | ||
| Cytosine methylation profiling of cancer cell lines. | Q36534546 | ||
| An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer | Q37187915 | ||
| Mutation analysis of 24 known cancer genes in the NCI-60 cell line set. | Q37250634 | ||
| Cadherins and cancer: how does cadherin dysfunction promote tumor progression? | Q37333596 | ||
| Transcript and protein expression profiles of the NCI-60 cancer cell panel: an integromic microarray study. | Q38516613 | ||
| Drug sensitivity prediction by CpG island methylation profile in the NCI-60 cancer cell line panel. | Q40040939 | ||
| MicroRNA expression profiles for the NCI-60 cancer cell panel | Q40136433 | ||
| Characterization of microRNA expression levels and their biological correlates in human cancer cell lines | Q40158414 | ||
| Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells | Q40220260 | ||
| Integrated genomic and proteomic analyses of gene expression in Mammalian cells | Q40538549 | ||
| An information-intensive approach to the molecular pharmacology of cancer. | Q41134023 | ||
| Tumor progression induced by the loss of E-cadherin independent of beta-catenin/Tcf-mediated Wnt signaling | Q42502782 | ||
| Integrated Molecular and Clinical Analysis of AKT Activation in Metastatic Melanoma | Q42723115 | ||
| Application of comparative functional genomics to identify best-fit mouse models to study human cancer | Q45163567 | ||
| An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis | Q47608135 | ||
| Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression | Q57693549 | ||
| An integrated database of chemosensitivity to 55 anticancer drugs and gene expression profiles of 39 human cancer cell lines | Q77678763 | ||
| Predicting cisplatin and trabectedin drug sensitivity in ovarian and colon cancers | Q95815092 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cancer cell line | Q23058136 |
| P304 | page(s) | 257-267 | |
| P577 | publication date | 2010-02-02 | |
| P1433 | published in | Molecular Cancer Therapeutics | Q2363144 |
| P1476 | title | Integrative analysis of proteomic signatures, mutations, and drug responsiveness in the NCI 60 cancer cell line set | |
| P478 | volume | 9 |
| Q39033381 | A Strategy to Combine Sample Multiplexing with Targeted Proteomics Assays for High-Throughput Protein Signature Characterization |
| Q36490656 | A database of reaction monitoring mass spectrometry assays for elucidating therapeutic response in cancer |
| Q33944976 | A pan-cancer proteomic perspective on The Cancer Genome Atlas. |
| Q35471445 | A phase I multi-institutional study of systemic sorafenib in conjunction with regional melphalan for in-transit melanoma of the extremity. |
| Q54530259 | A systematic modeling study on the pathogenic role of p38 MAPK activation in myelodysplastic syndromes |
| Q38846044 | AKT in cancer: new molecular insights and advances in drug development |
| Q37597919 | An Efficient Electroporation Protocol for the Genetic Modification of Mammalian Cells. |
| Q92510255 | An Interactive Resource to Probe Genetic Diversity and Estimated Ancestry in Cancer Cell Lines |
| Q36578468 | An efficient procedure for protein extraction from formalin-fixed, paraffin-embedded tissues for reverse phase protein arrays |
| Q38333966 | ApoCanD: Database of human apoptotic proteins in the context of cancer. |
| Q30985471 | BAYESIAN SPARSE GRAPHICAL MODELS FOR CLASSIFICATION WITH APPLICATION TO PROTEIN EXPRESSION DATA. |
| Q48113428 | BCN057 induces intestinal stem cell repair and mitigates radiation-induced intestinal injury |
| Q38520679 | BRAFV600E cooperates with PI3K signaling, independent of AKT, to regulate melanoma cell proliferation |
| Q42478581 | Basal and treatment-induced activation of AKT mediates resistance to cell death by AZD6244 (ARRY-142886) in Braf-mutant human cutaneous melanoma cells |
| Q92492990 | Bayesian data integration and variable selection for pan-cancer survival prediction using protein expression data |
| Q33818738 | Bioinformatic analyses identifies novel protein-coding pharmacogenomic markers associated with paclitaxel sensitivity in NCI60 cancer cell lines. |
| Q36274938 | Bouvardin is a Radiation Modulator with a Novel Mechanism of Action |
| Q37503954 | Cell line modeling for systems medicine in cancers (review). |
| Q47606195 | Comprehensive Analysis of Cancer-Proteogenome to Identify Biomarkers for the Early Diagnosis and Prognosis of Cancer. |
| Q35174664 | Coordinated regulation of mitochondrial topoisomerase IB with mitochondrial nuclear encoded genes and MYC |
| Q37700338 | Designing of promiscuous inhibitors against pancreatic cancer cell lines |
| Q35221345 | Development of a robust classifier for quality control of reverse-phase protein arrays |
| Q35889621 | Different mechanisms for resistance to trastuzumab versus lapatinib in HER2- positive breast cancers - role of estrogen receptor and HER2 reactivation |
| Q47123235 | Enhanced Missing Proteins Detection in NCI60 Cell Lines Using an Integrative Search Engine Approach |
| Q36021891 | ErbB3-ErbB2 Complexes as a Therapeutic Target in a Subset of Wild-type BRAF/NRAS Cutaneous Melanomas. |
| Q39144212 | Establishing a High-Throughput and Automated Cancer Cell Proliferation Panel for Oncology Lead Optimization |
| Q36393332 | Exploring genomic profiles of hepatocellular carcinoma. |
| Q35581611 | Fluorinated Amino-Derivatives of the Sesquiterpene Lactone, Parthenolide, as 19F NMR Probes in Deuterium-Free Environments |
| Q36919864 | Gene expression profiling of ampullary carcinomas classifies ampullary carcinomas into biliary-like and intestinal-like subtypes that are prognostic of outcome |
| Q36525420 | Glucose starvation induces mutation and lineage-dependent adaptive responses in a large collection of cancer cell lines |
| Q33903753 | Guidelines for the welfare and use of animals in cancer research |
| Q47391313 | Harnessing BET Inhibitor Sensitivity Reveals AMIGO2 as a Melanoma Survival Gene |
| Q27000665 | In vitro human cell line models to predict clinical response to anticancer drugs |
| Q41858308 | Lysophosphatidic Acid Induces Lymphangiogenesis and IL-8 Production in Vitro in Human Lymphatic Endothelial Cells |
| Q28487333 | Machine learning prediction of cancer cell sensitivity to drugs based on genomic and chemical properties |
| Q38148747 | Navigating the therapeutic complexity of PI3K pathway inhibition in melanoma |
| Q38846991 | Next-generation phenotypic screening |
| Q38906407 | PDK1 and SGK3 Contribute to the Growth of BRAF-Mutant Melanomas and Are Potential Therapeutic Targets |
| Q39640222 | PLX4032, a potent inhibitor of the B-Raf V600E oncogene, selectively inhibits V600E-positive melanomas |
| Q37197528 | Perspective: Opportunities in recalcitrant, rare and neglected tumors |
| Q30744596 | Postoperative chemotherapy use after neoadjuvant chemoradiotherapy for rectal cancer: Analysis of Surveillance, Epidemiology, and End Results-Medicare data, 1998-2007 |
| Q96172057 | Pre-clinical modeling of cutaneous melanoma |
| Q30010216 | Protein kinase Cα promotes cell migration through a PDZ-dependent interaction with its novel substrate discs large homolog 1 (DLG1) |
| Q38601402 | Proteins associated with the doubling time of the NCI-60 cancer cell lines |
| Q33962243 | Proteomic analysis identifies differentially expressed proteins after HDAC vorinostat and EGFR inhibitor gefitinib treatments in Hep-2 cancer cells. |
| Q28114915 | Reconstruction of nuclear receptor network reveals that NR2E3 is a novel upstream regulator of ESR1 in breast cancer |
| Q33799624 | Reconstruction of pathway modification induced by nicotinamide using multi-omic network analyses in triple negative breast cancer |
| Q82182829 | Regulation, Role, and Targeting of Akt in Cancer |
| Q39224151 | Resistance to BRAF Inhibition in BRAF-Mutant Colon Cancer Can Be Overcome with PI3K Inhibition or Demethylating Agents |
| Q38880745 | The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets |
| Q36354855 | Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer. |
| Q36213103 | c-Myc modulation: a key role in melanoma drug response |
| Q40097436 | dbEM: A database of epigenetic modifiers curated from cancerous and normal genomes. |
Search more.